Form 4: Viemed Healthcare President Michael Moore Reports Stock Transactions
SEC Form 4 Filing
Viemed Healthcare's President, Michael Moore, reported the vesting of restricted stock units and phantom share units, resulting in both acquisition and disposition of common shares.
Summary
- Michael Moore, President of Viemed Healthcare, reported several transactions involving the company's stock on January 29, 2025.
- These transactions include the vesting of 26,843 restricted stock units (RSUs), which converted into common shares.
- A portion of the vested shares, 8,147, were withheld to cover tax obligations.
- Additionally, 8,948 phantom share units vested, resulting in the acquisition of 8,948 common shares and a simultaneous disposition of the same amount for cash.
- The price per share for these transactions was $8.28, based on the market closing price on January 29, 2025.
- Following these transactions, Mr. Moore directly owns 177,433 common shares and indirectly owns 1,722,614 shares through Moore Faster LLC.
Sentiment
Score: 7
Explanation: The document reflects routine transactions related to executive compensation. It is neither particularly positive nor negative, but rather an expected part of the company's operations.
Industry Context
This is a routine filing related to executive compensation and is common for publicly traded companies. It reflects the vesting schedule of equity-based compensation for a key executive.
Comparison to Industry Standards
- The vesting of restricted stock units and phantom share units is a common practice in executive compensation packages across various industries.
- Companies like ResMed and AdaptHealth also use similar equity-based compensation methods for their executives.
- The specific vesting schedules and terms can vary, but the general concept of aligning executive interests with shareholder value through equity grants is standard practice.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they reflect the standard vesting of executive compensation.
- The transactions do not have a direct impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 01/29/2024 | Date of grant for Restricted Stock Units and Phantom Share Units which vest in three equal annual installments beginning on the first anniversary of the grant date. |
| 01/29/2025 | Date of the reported transactions, including vesting of RSUs and phantom share units. |
| 01/29/2027 | Expiration date for the Restricted Stock Units and Phantom Share Units. |
| 01/31/2025 | Date the Form 4 was signed. |
Keywords
Viemed Healthcare, Michael Moore, stock transactions, restricted stock units, phantom share units, insider trading, Form 4, equity compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.